Search clinical trials for: daltéparine

Total 242 results

Pfizer

Completed

Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice

Acute Coronary Syndrome

India
Centre Hospitalier Universitaire, Amiens

Recruiting

Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis (Aticks Live)

Inflammatory Response | Deep Vein Thrombosis

France
Ottawa Hospital Research Institute
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...

Terminated

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism (WAVe)

Obesity | Cancer | Venous Thromboembolism

Canada
Galician Research Group on Digestive Tumors
LEO Pharma

Recruiting

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer (PROTINCOL)

Thromboembolism | Colorectal Cancer Metastatic

Spain
Ottawa Hospital Research Institute

Completed

Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer (PERIOP-01)

Adenocarcinoma of the Colon

Canada, France, Belgium
Groupe Hospitalier Pitie-Salpetriere
Assistance Publique Hopitaux De Marseille

Completed

Venous Thromboprophylaxis in Bariatric Surgery (OBSUD)

Obesity
Ribe County Hospital
LEO Pharma; Coloplast A/S

Terminated

MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis

Inflammation | Peritoneal Dialysis | Nutrition

Denmark
Hospital Universitario Infanta Leonor

Completed

Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)

Covid19 | Thrombosis

Spain
Ottawa Hospital Research Institute
LEO Pharma

Completed

The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section

Deep Vein Thrombosis

Canada
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Dalteparin in Preventing DVT in Participants With Cancer

Soft Tissue Sarcoma | Lymphoma | Plasma Cell Myeloma | Bone Sarcoma | Femur Fracture | Metastatic Neoplasm | Pathologic Fracture

United States
University Medical Centre Ljubljana

Completed

Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis (REVETR)

Superficial Thrombophlebitis

Slovenia
Hull University Teaching Hospitals NHS Trust

Completed

Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer | Thromboembolism

United Kingdom
Loewenstein Hospital
Meir Medical Center

Unknown

LMWH-VTE Prophylaxis for Survivors of Acute Ischemic Stroke- Assessment of Standard Dosing Regimen

Stroke

Israel
Mohamed Sayed Mohamed Abbas

Completed

Anti-Xa Assay Correlation to the Efficacy and Safety of Enoxaparin in the Treatment of Pulmonary Embolism

Anti-Xa Assay in Pulmonary Embolism
University of Calgary
LEO Pharma

Completed

Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing

Venous Thromboembolism

Canada
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Terminated

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) (PROVE)

Venous Thromboembolism | Lung Neoplasm

France
Lawson Health Research Institute
Pfizer; Canadian Institutes of Health Research (CIHR)

Unknown

PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.

Stroke

India, Canada
Maisonneuve-Rosemont Hospital

Completed

Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses (STRIP)

Renal Insufficiency, Chronic | Deep Venous Thrombosis, Protection Against

Canada
University of Vermont
National Cancer Institute (NCI)

Unknown

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery

Kidney Cancer

United States
University of Calgary
Canadian Institutes of Health Research (CIHR); LEO Pharma; Dupont Applied Biosciences

Completed

Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)

Thrombosis | Venous Thrombosis | Thromboembolism

Canada
Gary Morrow
National Cancer Institute (NCI)

Terminated

Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Pancreatic Cancer | Thromboembolism

United States
M.D. Anderson Cancer Center
Eisai Inc.

Completed

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Pancreatic Cancer | Venous Thromboembolism

United States
University of Florence

Terminated

LMWH to Prevent Preeclampsia and Fetal Growth Restriction

Preeclampsia
HaEmek Medical Center, Israel

Completed

A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity

Obesity | Anticoagulant | Apixaban

Israel
Southeast University, China

Unknown

Anti-Xa Levels in Critically Ill Patients Receiving Low-molecular-weight Heparin for Thromboprophylaxis in China

Critically Ill | Anti-Xa

China
Lawson Health Research Institute
Pfizer

Completed

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

Embolism and Thrombosis

Canada
Sunnybrook Health Sciences Centre
Canadian Institutes of Health Research (CIHR); Sunnybrook Research Institute

Recruiting

PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) (PROTEST)

Traumatic Brain Injury

Canada
Azidus Brasil
Blau Farmaceutica S.A.

Completed

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration

Healthy

Brazil
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)

Atrial Fibrillation | Arterial Thromboembolic Events

United States
King Saud University
King AbdulAziz City for Science and Technology

Unknown

Venous Thromboembolism Prophylaxis Post Cesarean Section (PROCS)

Bleeding | Venous Thromboembolism

Saudi Arabia
University of Southern California
National Cancer Institute (NCI); Celgene Corporation

Terminated

Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma

United States
Anthos Therapeutics, Inc.
Itreas

Recruiting

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE (MAGNOLIA)

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Austria, United States, Taiwan, Australia, China, Spain, Korea, Republic of, Italy, Hungary, France, Netherlands, Latvia, Ireland, Germany, United Kingdom, Canada, Norway, Sweden, Czechia, Switzerland
University Hospital of Patras

Recruiting

Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients (INTERACT)

Covid19 | Hospitalization

Greece
University of Southern California
Celgene Corporation

Terminated

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

Cancer | Venous Thromboembolism

United States
Duke University
Eisai Limited

Completed

Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo

Sickle Cell Disease | Vaso-occlusive Crisis

United States
University of Calgary
Canadian Institutes of Health Research (CIHR); LEO Pharma; Dupont Applied Biosciences

Completed

Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin

Thrombosis | Venous Thrombosis | Thromboembolism

Canada
Hospices Civils de Lyon

Not yet recruiting

Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery) (AXAES)

Thrombosis | Aortic Diseases | Arterial Disease

France
Azidus Brasil

Completed

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose

Healthy

Brazil
St. Joseph's Healthcare Hamilton
LEO Pharma; Heart and Stroke Foundation of Ontario

Terminated

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Venous Thrombosis | Pulmonary Embolism

Canada
Ottawa Hospital Research Institute
LEO Pharma

Completed

Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer (PERI-OP)

Cancer | Deep Vein Thrombosis | Pulmonary Embolism

Canada
Imperial College London

Recruiting

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) (THRIVE)

Varicose Veins | Venous Thromboembolism

United Kingdom
LEO Pharma

Completed

Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) (PREDICARE)

Venous Thromboembolism

France
University of Aarhus
Aarhus University Hospital; LEO Pharma

Completed

Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight? (IUGR)

Fetal Growth Retardation

Denmark
University Medical Center Groningen
Radboud University Medical Center; Erasmus Medical Center; Academisch Medisch... and other collaborators

Recruiting

Reduced Anticoagulation Targets in ECLS (RATE) (RATE)

Heart Failure | Thrombosis | Respiratory Failure | Bleeding | Extracorporeal Membrane Oxygenation

Netherlands
AHEPA University Hospital

Completed

Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary Catheterization (LOW-RAO)

Arterial Occlusion

Greece
The Catholic University of Korea

Unknown

Optimal Prophylactic Method of Venous Thromboembolism (VTE)

Venous Thromboembolism

Korea, Republic of
Azienda Ospedaliera Universitaria Policlinico

Completed

Deferment of Imaging for Pulmonary Embolism

Pulmonary Embolism
Metaxa Hospital

Unknown

Metaxa Hospital THromboprophylaxis Program in Oncological & Surgical Patients (MeTHOS)

Thrombosis | Solid Cancer

Greece
Azienda Ospedaliera Universitaria Policlinico

Unknown

Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis (Cancer-DACUS)

Cancer | Deep Vein Thrombosis

Italy
Medical University of Gdansk
Baxter Healthcare Corporation

Unknown

Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.

Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis

Poland

Search clinical trials for: daltéparine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations